268234-39-5

Basic information

• Product Name: (E)-5-{3-[(3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl)methylamino]phenyl}hex-4-enoic acid
• Synonyms: (E)-5-{3-[(3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl)methylamino]phenyl}hex-4-enoic acid
• CAS NO: 268234-39-5
• Molecular Weight: 597.986
• Mol File: 268234-39-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-5-{3-[(3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl)methylamino]phenyl}hex-4-enoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-5-{3-[(3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl)methylamino]phenyl}hex-4-enoic acid(268234-39-5)
• EPA Substance Registry System: (E)-5-{3-[(3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl)methylamino]phenyl}hex-4-enoic acid(268234-39-5)

Safety Data

• Hazardous Substances Data: 268234-39-5(Hazardous Substances Data)

Upstream product

• 268234-38-4 1-(3-{[3,4-bis(tert-butyldimethylsilanyloxymethyl)benzyl]methylamino}phenyl)ethanone 
• 17857-14-6 (3-carboxypropyl)(triphenyl)phosphonium bromide 

Downstream Products

• 268231-88-5 (E)-7-{3-[(3,4-Bis-hydroxymethylbenzyl)methylamino]-phenyl}-3-ethyloct-6-en-3-ol 

Relevant articles and documents

Vitamin D analogues

The invention concerns novel bi-aromatic compounds having the formula: which are analogs of vitamin D, the process of preparing them, as well as their use in pharmaceutical compositions in human or veterinary medicine, particularly in dermatology, cancer treatment, treatment of auto-immune diseases, and in organ or tissue transplants. Cosmetic compositions and methods of use are also included.